US Patent 11421265 Optimization of multigene analysis of tumor samples
Patent 11421265 was granted and assigned to Foundation Medicine on August, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 11, 2019
0
Date of Patent
August 23, 2022
0
Patent Applicant
Patent Application Number
16245301
0
Patent Citations Received
Patent Inventor Names
Alexander Nevin Parker
0
Doron Lipson
0
Geoffrey Alan Otto
0
Mikhail G. Shapiro
0
Mima Jarosz
0
Philip James Stephens
0
Roman Yelensky
0
Sean R. Downing
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11421265 Optimization of multigene analysis of tumor samples
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.